Abstract

Methods The project included: identification of existing SAP guidance; identifying and reviewing published SAPs; a survey of current practice within UKCRC registered Clinical Trial Units (rCTU) and a Delphi survey to establish consensus on SAP content. The Delphi survey included rCTU statisticians, CONSORT and SPIRIT guideline authors, experienced statisticians in the pharmaceutical industry, journal editors and regulators culminating in a face-to-face consensus meeting attended by experts from each demographic. These components informed the development of guidance for SAPs which subsequently underwent critical review by rCTU statisticians and experts from the consensus meeting, followed by piloting of the guidance document.

Highlights

  • ICH E9 guidelines recommend that a detailed SAP is prepared before breaking the trial blind

  • The Delphi survey included registered Clinical Trial Units (rCTU) statisticians, CONSORT and SPIRIT guideline authors, experienced statisticians in the pharmaceutical industry, journal editors and regulators culminating in a face-to-face consensus meeting attended by experts from each demographic

  • These components informed the development of guidance for SAPs which subsequently underwent critical review by rCTU statisticians and experts from the consensus meeting, followed by piloting of the guidance document

Read more

Summary

Open Access

Development of guidance for statistical analysis plans (SAPs) for clinical trials. Ashma Krishan1*, Deborah Stocken, Steff Lewis, Ed Juszczak, Caroline Dore, Paula Williamson, Doug Altman, Alan Montgomery, Mike Clarke, Carrol Gamble. From 3rd International Clinical Trials Methodology Conference Glasgow, UK. From 3rd International Clinical Trials Methodology Conference Glasgow, UK. 16-17 November 2015

Methods
Conclusions
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.